site stats

Biosyent investor

WebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of a bust so far, with the stock ... WebMar 24, 2024 · BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It owns a legacy business that manufactures and markets Protect-It, a bio-friendly non-toxic product used in agriculture, which is operated by its subsidiary Hedley Technologies Ltd.

BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor …

WebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … WebMar 9, 2024 · Investor Takeaway. BioSyent appears to be fairly valued. The company is expected to report Q4 earnings on March 21, 2024, and it will be important to see the percentage growth of FeraMAX sales in ... orchidea bouquet https://tactical-horizons.com

BioSyent: A Great Micro Cap (OTCMKTS:BIOYF) Seeking Alpha

WebFeb 1, 2024 · Article content. MISSISSAUGA, Ontario, Feb. 01, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on March 15, 2024, to shareholders of record at the close of … WebFeb 24, 2024 · 1.3% of BioSyent shares are held by institutional investors. 40.6% of BioSyent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. WebBioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … ir thicket\\u0027s

BioSyent (TSXV:RX) - Stock Price, News & Analysis - Simply Wall St

Category:BioSyent Inc.

Tags:Biosyent investor

Biosyent investor

BioSyent Releases Financial Results for Fourth Quarter and Full …

WebApr 26, 2024 · MISSISSAUGA, Ontario, April 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co ... WebSep 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities. The MicroCap Leadership Summit is attended by retail and ...

Biosyent investor

Did you know?

WebBioSyent Inc. Listed on the TSX Venture Exchange (TSXV: RX) BioSyent is a profitable growth oriented speciality pharmaceutical company which searches the globe to in … WebOct 28, 2013 · BioSyent only has 13.5 million shares outstanding (14.5m FD), 43% controlled by the management and the board. BioSyent's CEO Rene Goehrum owns 18% of the company, and CFO Alfred D'Souza owns 11%. Mr.

WebNov 17, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that … WebMar 31, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be …

WebApr 9, 2024 · The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, … WebNov 16, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that …

WebApr 6, 2024 · A high-level overview of BioSyent Inc. (BIOYF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ...

orchidea cserép 10WebMar 21, 2024 · MISSISSAUGA, Ontario, March 21, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and … orchidea boccioliWebMar 31, 2024 · For further information please contact: Mr. Rene C. Goehrum President and CEO BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. orchidea bresciaWebMar 31, 2024 · For further information please contact: Mr. René C. Goehrum President and CEO BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and … orchidea cerviahttp://www.biosyent.com/rx/investor_center/ ir to ck3 converterhttp://www.biosyent.com/rx/home/ ir thin filmWebBioSyent is continuously is looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then … ir to ck3